Myeloid cell expressed proprotein convertase FURIN attenuates inflammation

The proprotein convertase enzyme FURIN processes immature pro-proteins into functional end- products. FURIN is upregulated in activated immune cells and it regulates T-cell dependent peripheral tolerance and the Th1/Th2 balance. FURIN also promotes the infectivity of pathogens by activating bacterial toxins and by processing viral proteins. Here, we evaluated the role of FURIN in LysM+ myeloid cells in vivo. Mice with a conditional deletion of FURIN in their myeloid cells (LysMCre-fur(fl/fl)) were healthy and showed unchanged proportions of neutrophils and macrophages. Instead, LysMCre-fur(fl/fl) mice had elevated serum IL-1β levels and reduced numbers of splenocytes. An LPS injection resulted in accelerated mortality, elevated serum pro-inflammatory cytokines and upregulated numbers of pro-inflammatory macrophages. A genome-wide gene expression analysis revealed the overexpression of several pro-inflammatory genes in resting FURIN-deficient macrophages. Moreover, FURIN inhibited Nos2 and promoted the expression of Arg1, which implies that FURIN regulates the M1/M2-type macrophage balance. FURIN was required for the normal production of the bioactive TGF-β1 cytokine, but it inhibited the maturation of the inflammation-provoking TACE and Caspase-1 enzymes. In conclusion, FURIN has an anti-inflammatory function in LysM+ myeloid cells in vivo.

[1]  M. Locati,et al.  Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways , 2015, The Journal of Immunology.

[2]  Takuji Yamada,et al.  The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory , 2015, Nature Immunology.

[3]  W. Garten,et al.  Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics. , 2015, European journal of cell biology.

[4]  C. Ortutay,et al.  Proprotein convertase FURIN regulates T cell receptor‐induced transactivation , 2015, Journal of leukocyte biology.

[5]  V. Cerundolo,et al.  The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct Human TLR7 into Endosomes , 2015, The Journal of Immunology.

[6]  Daniel G. Anderson,et al.  Macrophages retain hematopoietic stem cells in the spleen via VCAM-1 , 2015, The Journal of experimental medicine.

[7]  M. Waldenberger,et al.  A genome-wide expression quantitative trait loci analysis of proprotein convertase subtilisin/kexin enzymes identifies a novel regulatory gene variant for FURIN expression and blood pressure , 2015, Human Genetics.

[8]  R. Day,et al.  Therapeutic uses of furin and its inhibitors: a patent review , 2015, Expert opinion on therapeutic patents.

[9]  Jie Du,et al.  Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration* , 2015, The Journal of Biological Chemistry.

[10]  B. Guérin,et al.  PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation , 2015, Oncotarget.

[11]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[12]  G. Corthals,et al.  Proprotein Convertase FURIN Constrains Th2 Differentiation and Is Critical for Host Resistance against Toxoplasma gondii , 2014, The Journal of Immunology.

[13]  K. Feingold,et al.  Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages , 2014, Journal of Lipid Research.

[14]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[15]  Zachary D. Kurtz,et al.  Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. , 2014, Blood.

[16]  B. Ryffel,et al.  Interleukin-33 Increases Antibacterial Defense by Activation of Inducible Nitric Oxide Synthase in Skin , 2014, PLoS pathogens.

[17]  G. Nath,et al.  Proteomics-based identification of plasma proteins and their association with the host–pathogen interaction in chronic typhoid carriers , 2013, International Journal of Infectious Diseases.

[18]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[19]  M. Nykter,et al.  Proprotein Convertase Subtilisin/Kexin Type 7 (PCSK7) Is Essential for the Zebrafish Development and Bioavailability of Transforming Growth Factor β1a (TGFβ1a)* , 2013, The Journal of Biological Chemistry.

[20]  E. Raines,et al.  Macrophage ADAM17 Deficiency Augments CD36-Dependent Apoptotic Cell Uptake and the Linked Anti-Inflammatory Phenotype , 2013, Circulation research.

[21]  Y. Belkaid,et al.  Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection , 2013, Nature Medicine.

[22]  D. Kalvakolanu,et al.  The Transcription Factor C/EBP-β Mediates Constitutive and LPS-Inducible Transcription of Murine SerpinB2 , 2013, PloS one.

[23]  I. De Noni,et al.  S-Layer Protein Mediates the Stimulatory Effect of Lactobacillus helveticus MIMLh5 on Innate Immunity , 2012, Applied and Environmental Microbiology.

[24]  F. Boudreau,et al.  Role of proprotein convertases in prostate cancer progression. , 2012, Neoplasia.

[25]  J. Larghero,et al.  Protective role of systemic furin in immune response-induced arthritis. , 2012, Arthritis and rheumatism.

[26]  A. Prat,et al.  Loss of Endothelial Furin Leads to Cardiac Malformation and Early Postnatal Death , 2012, Molecular and Cellular Biology.

[27]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[28]  N. Seidah,et al.  Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion* , 2012, The Journal of Biological Chemistry.

[29]  D. Rao,et al.  Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  S. Gordon,et al.  CD169+ macrophages at the crossroads of antigen presentation. , 2012, Trends in immunology.

[31]  C. Blobel,et al.  iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS , 2012, Science.

[32]  F. Al-Mulla,et al.  Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. , 2011, Molecular bioSystems.

[33]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[34]  T. McGaha,et al.  Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. , 2011, Blood.

[35]  T. Ohsugi,et al.  Low CD4/CD8 T-Cell Ratio Associated with Inflammatory Arthropathy in Human T-Cell Leukemia Virus Type I Tax Transgenic Mice , 2011, PloS one.

[36]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[37]  M. Knittler,et al.  Post-Endoplasmic Reticulum Rescue of Unstable MHC Class I Requires Proprotein Convertase PC7 , 2010, The Journal of Immunology.

[38]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[39]  A. Surprenant,et al.  Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates , 2009, The EMBO journal.

[40]  R. Schwendener,et al.  Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. , 2009, Cancer research.

[41]  Seth L Masters,et al.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). , 2009, Annual review of immunology.

[42]  L. Joosten,et al.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. , 2009, Blood.

[43]  Y. Belkaid,et al.  T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance , 2008, Nature.

[44]  S. Sicherer,et al.  Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition , 2007, Pediatrics.

[45]  Jeffrey W. Smith,et al.  Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens* , 2007, Journal of Biological Chemistry.

[46]  J. O’Shea,et al.  Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. , 2006, Blood.

[47]  S. Leppla,et al.  Anthrax target in macrophages unveiled , 2006, Nature Genetics.

[48]  I. Fournier,et al.  Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen , 2006, Journal of Neuroimmunology.

[49]  S. Opal,et al.  Inter-Alpha-Inhibitor Proteins Are Endogenous Furin Inhibitors and Provide Protection against Experimental Anthrax Intoxication , 2005, Infection and Immunity.

[50]  A. Lauwers,et al.  Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver* , 2004, Journal of Biological Chemistry.

[51]  G. Reyes-Terán,et al.  Molecular mechanisms involved in the pathogenesis of septic shock. , 2004, Archives of medical research.

[52]  M. Chatterji,et al.  INFECTION-INDUCED MODULATION OF M1 AND M2 PHENOTYPES IN CIRCULATING MONOCYTES: ROLE IN IMMUNE MONITORING AND EARLY PROGNOSIS OF SEPSIS , 2004, Shock.

[53]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[54]  S. Brody,et al.  IL-12 p40 Homodimer-Dependent Macrophage Chemotaxis and Respiratory Viral Inflammation Are Mediated through IL-12 Receptor β1 1 , 2003, The Journal of Immunology.

[55]  G. Morahan.  Faculty Opinions recommendation of IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. , 2003 .

[56]  I. Fournier,et al.  TACE/ADAM‐17 maturation and activation of sheddase activity require proprotein convertase activity , 2003, FEBS letters.

[57]  W. V. D. Van de Ven,et al.  Curbing activation: proprotein convertases in homeostasis and pathology , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  E. Kojro,et al.  Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. , 2003, European journal of biochemistry.

[59]  N. Seidah,et al.  The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. , 2003, The Journal of clinical investigation.

[60]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[61]  R. Black,et al.  Tumor necrosis factor-alpha converting enzyme. , 2002, The international journal of biochemistry & cell biology.

[62]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[63]  N. Seidah,et al.  Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. , 2001, The American journal of pathology.

[64]  P. Krebsbach,et al.  Bone marrow stromal cells: characterization and clinical application. , 1999, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[65]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[66]  C. Dubois,et al.  TGFbeta1 regulates gene expression of its own converting enzyme furin. , 1997, The Journal of clinical investigation.

[67]  N. Seidah,et al.  Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160 , 1997, FEBS letters.

[68]  D. Reisman,et al.  Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. , 1995, Oncogene.